Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bavarian Nordic R/I Ord (BVNKF)

Bavarian Nordic R/I Ord (BVNKF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.28
Trade BVNKF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
46.0000 unch
on 04/19/21
46.9551 -2.03%
on 04/08/21
+1.0000 (+2.22%)
since 03/19/21
3-Month
35.3500 +30.13%
on 03/02/21
46.9551 -2.03%
on 04/08/21
+15.9100 (+52.87%)
since 12/09/20
52-Week
15.8900 +189.49%
on 04/21/20
46.9551 -2.03%
on 04/08/21
+14.7000 (+46.96%)
since 03/16/20

Most Recent Stories

More News
Bavarian Nordic Assists Public Health England in Response to New Cases of Monkeypox

COPENHAGEN, Denmark, June 11, 2021 - Bavarian Nordic A/S (OMX: BAVA) announced today that the Company was recently engaged by Public Health England (PHE) and the Medicines and Health Products Regulatory...

BVNKF : 46.0000 (-1.94%)
Updated Recommendations from the World Health Organization Further Support Use of Ebola Vaccine Regimen from Johnson & Johnson and Bavarian Nordic

COPENHAGEN, Denmark, June 7, 2021 - Bavarian Nordic A/S (OMX: BAVA) today announced that the Strategic Advisory Group of Experts (SAGE) on Immunization for the World Health Organization (WHO) has released...

BVNKF : 46.0000 (-1.94%)
Bavarian Nordic Announces Interim Results for the First Three Months of 2021

COPENHAGEN, Denmark, May 27, 2021 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results and business progress for the first three months of 2021.

BVNKF : 46.0000 (-1.94%)
Bavarian Nordic Announces Marketing and Distribution Agreement with Dynavax to Launch HEPLISAV B(R) Hepatitis B Vaccine in Germany

COPENHAGEN, Denmark, May 27 2021 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has entered a partnership with Dynavax Technologies Corporation (Nasdaq: DVAX) a biopharmaceutical company focused on developing...

BVNKF : 46.0000 (-1.94%)
DVAX : 10.33 (+4.55%)
Ebola Vaccine Regimen from Johnson & Johnson and Bavarian Nordic Supports World Health Organization in Efforts to Prevent Spread of Ebola in West Africa

COPENHAGEN, Denmark, May 17, 2021 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced that its partner Johnson & Johnson is supporting efforts by the World Health Organization (WHO) to prevent...

BVNKF : 46.0000 (-1.94%)
U.S. Government Exercises Option for Supply of Additional Smallpox Vaccines from Bavarian Nordic

COPENHAGEN, Denmark, May 7, 2021 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the U.S. Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant...

BVNKF : 46.0000 (-1.94%)
Bavarian Nordic rapporterer nye praekliniske resultater for COVID-19 vaccine, der bekraefter potentiale for bred beskyttelse mod SARS-CoV2-virusvarianter

KOBENHAVN, Danmark, 29. april 2021 - Bavarian Nordic A/S (OMX: BAVA) rapporterede i dag yderligere praekliniske resultater for COVID-19 vaccinekandidaten, ABNCoV2, som er baseret pa en capsid virus like...

BVNKF : 46.0000 (-1.94%)
Bavarian Nordic Reports New Preclinical Data for COVID-19 Vaccine Confirming Potential for Broad Protection against SARS-CoV2 Variants

COPENHAGEN, Denmark, April 29, 2021 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today reported additional preclinical data for the capsid virus-like particle (cVLP) COVID-19 vaccine candidate, ABNCoV2,...

BVNKF : 46.0000 (-1.94%)
Bavarian Nordic Receives Order to Manufacture Additional Ebola Vaccines

COPENHAGEN, Denmark, April 6, 2021 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company has received a new supply order from Janssen Pharmaceutica NV, part of the Janssen Pharmaceutical...

BVNKF : 46.0000 (-1.94%)
Bavarian Nordic modtager ordre pa produktion af yderligere ebolavacciner

KOBENHAVN, Danmark, 6. april 2021 - Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet har modtaget en ny ordre fra Janssen Pharmaceutica NV, en del af Janssen Pharmaceutical Companies of Johnson...

BVNKF : 46.0000 (-1.94%)

Key Turning Points

3rd Resistance Point 46.0000
2nd Resistance Point 46.0000
1st Resistance Point 46.0000
Last Price 46.0000
1st Support Level 46.0000
2nd Support Level 46.0000
3rd Support Level 46.0000

See More

52-Week High 46.9551
Last Price 46.0000
Fibonacci 61.8% 35.0882
Fibonacci 50% 31.4226
Fibonacci 38.2% 27.7569
52-Week Low 15.8900

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar